Novel approaches to treating leptomeningeal metastases (Q37923386)

25 August 2017

1 reference

title

Novel approaches to treating leptomeningeal metastases (English)

1 reference

25 August 2017

Jai Grewal

1

1 reference

PubMed ID

21874597

25 August 2017

Marlon Garzo Saria

series ordinal

2

1 reference

PubMed ID

21874597

25 August 2017

Santosh Kesari

series ordinal

3

1 reference

25 August 2017

28 August 2011

1 reference

Journal of Neuro-Oncology

25 August 2017

1 reference

25 August 2017

106

1 reference

25 August 2017

2

1 reference

25 August 2017

225-234

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-011-0686-2

25 August 2017

0 references

cites work

Neoplastic meningitis

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Meningeal carcinomatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Treatment for meningeal carcinomatosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Cytologic characteristics of meningeal carcinomatosis: increased diagnostic accuracy using carcinoembryonic antigen and epithelial membrane antigen immunocytochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Brain metastases: epidemiology and pathophysiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Malignant cells in cerebrospinal fluid (CSF): The meaning of a positive CSF cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Treatment of CNS dissemination in systemic lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

The use of flow cytometry in the diagnosis and monitoring of malignant hematological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Trafficking of activated cytotoxic T lymphocytes into the central nervous system: use of a transgenic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

The pathogenesis of neoplastic meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Circulating tumor cells and bone marrow micrometastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Vascular endothelial growth factor in CSF: a biological marker for carcinomatous meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Identification of invasion specific splice variants of the cytoskeletal protein Mena present in mammary tumor cells during invasion in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Molecular pathogenesis of primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

A Mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Immunoglobulin gene rearrangement analysis in cerebrospinal fluid of patients with lymphoproliferative processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

CSF evaluation in primary CNS lymphoma patients by PCR of the CDR III IgH genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Systemic chemotherapy, intrathecal chemotherapy, and symptom management in the treatment of leptomeningeal metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Leukemic and lymphomatous meningitis: incidence, prognosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Ventriculoperitoneal shunt in patients with leptomeningeal metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Ventriculoperitoneal shunting of idiopathic normal pressure hydrocephalus increases midbrain size: a potential mechanism for gait improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Palliative ventriculoperitoneal shunt in a pediatric patient with recurrent metastatic medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Efficacy and safety of liposomal cytarabine in lymphoma patients with central nervous system involvement from lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Drug Insight: intracellular inhibitors of HER2--clinical development of lapatinib in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Response and resistance in a non-small-cell lung cancer patient with an epidermal growth factor receptor mutation and leptomeningeal metastases treated with high-dose gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Successful treatment of leptomeningeal metastases from breast cancer using the combination of trastuzumab and capecitabine: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Capecitabine therapy of central nervous system metastases from breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Long-term clinical response in leptomeningeal metastases from breast cancer treated with capecitabine monotherapy: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Dramatic response with capecitabine after cranial radiation to the brain parenchymal and leptomeningeal metastases from lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

The seed and soil hypothesis: vascularisation and brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Brain metastases: 1995. A brief review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

The therapeutic use of rituximab in non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Recurrent lymphomatous meningitis treated with intra-CSF rituximab and liposomal ara-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516 -- the Southwest Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

To protect and defend: central nervous system prophylaxis in patients with non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0686-2

Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease

21 January 2018

1 reference

12 December 2020

Bevacizumab in the treatment of a patient with metastatic colorectal carcinoma with brain metastases

1 reference

12 December 2020

Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow status

1 reference

12 December 2020

Monoclonal antibody therapy of cancer

1 reference

12 December 2020

Successful treatment of leptomeningeal disease in colorectal cancer with a regimen of bevacizumab, temozolomide, and irinotecan

1 reference

12 December 2020

Neoplastic meningitis

1 reference

12 December 2020

Ventriculoperitoneal shunt in patients with leptomeningeal metastasis

1 reference

12 December 2020

Choroid plexus: target for systemic disease and pathway to the brain

1 reference

12 December 2020

Relapse in the central nervous system in melanoma patients successfully treated with biomodulators

1 reference

12 December 2020

Leptomeningeal metastasis

1 reference

12 December 2020

Leptomeningeal metastases: analysis of 31 patients with sustained off-therapy response following combined-modality therapy

1 reference

12 December 2020

In situ hybridization: a possible diagnostic aid in leptomeningeal metastasis

1 reference

12 December 2020

Care and management of the child with shunted hydrocephalus

1 reference

12 December 2020

Leptomeningeal metastases

1 reference

12 December 2020

Quantification of cerebrospinal fluid shunt flow rates. Assessment of the programmable pressure valve

1 reference

12 December 2020

Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells

1 reference

12 December 2020

Characteristic features of malignant lymphoma with central nervous system involvement

1 reference

12 December 2020

Treatment of leptomeningeal metastases evaluated by interphase cytogenetics

1 reference

12 December 2020

Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis.

1 reference

12 December 2020

Current treatment of leptomeningeal metastases: systemic chemotherapy, intrathecal chemotherapy and symptom management.

1 reference

12 December 2020

Leptomeningeal dissemination of ovarian carcinoma through a ventriculoperitoneal shunt

1 reference

12 December 2020

Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia

1 reference

12 December 2020

Two cases of leptomeningeal metastases from lung adenocarcinoma which progressed during gefitinib therapy but responded to erlotinib.

1 reference

12 December 2020

Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results

1 reference

12 December 2020

Metastatic CNS lymphoma presenting with periventricular dissemination - MRI and neuropathological findings in an autopsy case

1 reference

12 December 2020

Objective response with lapatinib in patients with meningitis carcinomatosa derived from HER2/HER1-negative breast cancer

1 reference

12 December 2020

https://opencitations.net/index/api/v1/citations/10.1200/JCO.2005.01.131

Neoplastic Meningitis

1 reference

3 January 2024

Identifiers

DOI

10.1007/S11060-011-0686-2

1 reference

25 August 2017

1 reference

PubMed ID

21874597